Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Zanubrutinib”

197 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 197 results

Testing effectiveness (Phase 2)Looking for participantsNCT06563505
What this trial is testing

Trial of Mosunetuzumab and Zanubrutinib for Patients With Relapsed/Refractory Marginal Zone Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 36
Testing effectiveness (Phase 2)UnknownNCT05940051
What this trial is testing

Prospective Clinical Study of ZPR Regimen in Relapsed/Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Peng Liu 35
Early research (Phase 1)Active Not RecruitingNCT06824701
What this trial is testing

Tazemetostat in Combination With Zanubrutinib and Anti-CD20 Monoclonal Antibody in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
University of Utah 24
Early research (Phase 1)Not Yet RecruitingNCT07315373
What this trial is testing

Optimal Dose of Zanubrutinib to Treat Adult Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 60
Testing effectiveness (Phase 2)Study completedNCT05068440
What this trial is testing

Treatment of CD79B Mutant Relapsed/Refractory Diffuse Large B-Cell Lymphoma With Bruton Tyrosine Kinase Inhibitor Zanubrutinib

Who this might be right for
Relapsed Diffuse Large B-cell LymphomaRefractory Diffuse Large B-cell Lymphoma
BeiGene 65
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06652165
What this trial is testing

Zanubrutinib Combined With BEAM for ASCT in Relapsed and Refractory DLBCL

Who this might be right for
DLBCL
Ruijin Hospital 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT03162536
What this trial is testing

Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

Who this might be right for
Lymphoma, B-CellSmall Lymphocytic LymphomaChronic Lymphocytic Leukemia+6 more
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 190
Testing effectiveness (Phase 2)Looking for participantsNCT06812715
What this trial is testing

Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib After Previous Treatment With Zanubrutinib

Who this might be right for
Chronic Lymphocytic Leukemia
Peter MacCallum Cancer Centre, Australia 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07405255
What this trial is testing

Zillion: Zanubrutinib Combined With Chemotherapy for Newly Diagnosed CNS Lymphoma

Who this might be right for
Central Nervous System Lymphoma
Ruijin Hospital 19
Testing effectiveness (Phase 2)Looking for participantsNCT06375733
What this trial is testing

GFH009 in Combination With Zanubrutinib in Subjects With Relapsed or Refractory DLBCL

Who this might be right for
Large B-cell Lymphoma
Genfleet Therapeutics (Shanghai) Inc. 51
Large-scale testing (Phase 3)Active Not RecruitingNCT05707377
What this trial is testing

Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
BeOne Medicines 178
Testing effectiveness (Phase 2)Looking for participantsNCT05214391
What this trial is testing

A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 30
Testing effectiveness (Phase 2)UnknownNCT05887726
What this trial is testing

Zanubrutinib Combined With R-CHOP Regimen in the Treatment of Newly Diagnosed DLBCL With High-risk Factors

Who this might be right for
Diffuse Large B Cell Lymphoma
Liaoning Cancer Hospital & Institute 30
Early research (Phase 1)Active Not RecruitingNCT04850495
What this trial is testing

Zanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaTransformed Follicular Lymphoma to Diffuse Large B-Cell LymphomaTransformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma
Yazeed Sawalha 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07505849
What this trial is testing

ZR2 Versus R2 Regimen in the Treatment of Newly Diagnosed Follicular Lymphoma

Who this might be right for
Follicular Lymphomas
KeshuZhou 100
Early research (Phase 1)Study completedNCT05767398
What this trial is testing

Bioequivalence of a Zanubrutinib Tablet Compared to Capsules in Healthy Adult Participants

Who this might be right for
Healthy Volunteers
BeiGene 58
Not applicableNot Yet RecruitingNCT07711327
What this trial is testing

Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy

Who this might be right for
Atrial Fibrillation (AF)Chronic Lymphocytic LeukemiaWaldenstrom Macroglobulinemia+2 more
Tina Baykaner 500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06646211
What this trial is testing

High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)

Who this might be right for
Primary Central Nervous System Lymphoma (PCNSL)Non Hodgkin Lymphoma (NHL)
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Study completedNCT04382586
What this trial is testing

Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

Who this might be right for
COVID-19 Pulmonary ComplicationsCOVID-19
BeiGene 63
Testing effectiveness (Phase 2)Looking for participantsNCT06839053
What this trial is testing

Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaMantle Cell LymphomaRecurrent Chronic Lymphocytic Leukemia+6 more
Fred Hutchinson Cancer Center 30
Next Page